Abstract
The intramuscular use of botulinum toxin (Botox) for the purpose of neuromuscular blockade is accepted therapy for certain ocular and facial muscular imbalances, and its mechanism of action has been well described.1–15 The therapeutic use of Botox in larger skeletal muscle groups is not as well established. Direct intramuscular injections of Botox into the stemocleidomastoid, trapezius, and splenii muscles have resulted in clinical improvement in spasmodic torticollis;16,17 preliminary studies using Botox to treat focal foot and hand dystonias, upper limb spasticity in stroke patients, and spastic adductor muscles in patients with multiple sclerosis have been reported.4,5,18 Until recently, however, there have been no reports of Botox being used to manage the spasticity of cerebral palsy. Before discussing the use of Botox in this population, it is important to present a general overview of the pathophysiology of cerebral palsy and to point out the large number of patients with this disorder.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Alpar AJ. Botulinum toxin and its uses in the treatment of ocular disorders. Am J Optom Physiol Optics 1987; 64: 79.
Arthurs B, Flanders M, Codere F, Gauthier S, Dresner S, Stone L. Treatment of blepharospasm with medication, surgery and Type A botulinum toxin. Can J Ophthalmol 1987; 22: 24.
Carruthers J, Stubbs HA. Botulinum toxin for benign essential blepharospasm, hemifacial spasm and age-related lower eyelid entropion. Can J Neurol Sci 1987; 14: 42.
Cohen LG, Hallett M, Geller BD, Hochberg F. Treatment of focal dystonias of the hand with botulinum toxin injections. J Neurol Neurosurg Psychiatry 1989; 52: 355.
Das TK, Park DM. Botulinum toxin in treating spasticity. Br J Clin Pract 1989; 43: 401.
Dutton JJ, Buckley EG. Botulinum toxin in the management of blepharospasm. Arch Neurol 1986; 43: 380.
Elston JS. Botulinum toxin therapy for involuntary facial movement. Eye 1988; 2: 12.
Kraft SP, Lang AE. Cranial dystonia, blepharospasm and hemifacial spasm: Clinical features and treatment, including the use of botulinum toxin. Can Med Assoc J 1988; 139: 837.
Ludlow CL, Naunton RF, Sedory SE, Schulz GM, Hallett M. Effects of botulinum toxin injections on speech in adductor spasmodic dysphonia. Neurology 1988; 38: 1220.
Miller RH, Woodson GE, Jankovic J. Botulinum toxin injection of the vocal fold for spasmodic dysphonia. A preliminary report. Arch Otolaryngol Head Neck Surg 1987; 113: 603.
Tsui JKC, Eisen A, Caine DB. Botulinum toxin in spasmodic torticollis. Adv Neurol 1988; 50: 593.
Tsui JK, Eisen A, Mak E, Carruthers J, Scott A, Caine DB. A pilot study on the use of botulinum toxin in spasmodic torticollis. Can J Neurol Sci 1985; 12: 314.
Tsui JKC, Fross RD, Caine S, Caine DB. Local treatment of spasmodic torticollis with botulinum toxin. Can J Neurol Sci 1987; 14: 533.
Tsui JKC, Eisen A, Stoessl AJ, Caine S, Caine DB. Double-blind study of botulinum toxin in spasmodic torticollis. Lancet 1986; 2: 245.
Brin MF, Fahn S, Moskowitz C, Friedman A, Shale HM, Greene PE, Blitzer A, List T, Lange D, Lovelace, RE, McMahon D. Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm. Mov Disord 1987; 2: 237.
Gelb DJ, Lowenstein DH, Aminoff MJ. Controlled trial of botulinum toxin injections in the treatment of spasmodic torticollis. Neurology 1989; 39: 80.
Stell R, Thompson PD, Marsden DC. Botulinum toxin in spasmodic torticollis. J Neurol Neurosurg Psychiatry 1988; 51: 920.
Tsui JKC, Snow B, Bhatt M, Varelas M, Hashimoto S, Caine DB. New applications of botulinum toxin in the lower limbs (Abstract). Neurology 1990; 40 (Suppl 1): 382.
Bleck EE. Orthopaedic Management in Cerebral Palsy. Philadelphia: J.B. Lippincott (1987).
Cerebral Palsy—Facts and Figures (Fact Sheet). United Cerebral Palsy Association, Inc., New York, August 9 (1986).
Barabas G, Taft LT. The early signs and differential diagnosis of cerebral palsy. Pediatr Ann 1986; 15: 203.
Albright AL, Cervi A, Singletary J. Intrathecal baclofen for spasticity in cerebral palsy, JAMA 1991; 265: 1418.
Diamond M. Rehabilitation strategies for the child with cerebral palsy. Pediatr Ann 1986; 15: 230.
Peacock WJ, Arens LJ, Berman B. Cerebral palsy spasticity. Selective posterior rhizotomy. Pediatr Neurosci 1987; 13: 61.
Silver RL, de la Garza J, Rang M. The myth of muscle balance: A study of relative strengths and excursions of normal muscles about the foot and ankle. J Bone Joint Surg 1985; 67-B:432.
Piper MC, Kunos VI, Willis DM, Mazer BL, Ramsay M, Silver KM. Early physical therapy effects on the high-risk infant: A randomized controlled trial. Pediatrics 1986; 78: 216.
Wright T, Nicholson J. Physiotherapy for the spastic child: An evaluation. Dev Med Child Neurol 1973; 15: 146.
Carpenter EB. Role of nerve blocks in the foot and ankle in cerebral palsy: Therapeutic and diagnostic. Foot Ankle 1983; 4: 164.
Carpenter EB, Seitz DG. Intramuscular alcohol as an aid in management of spastic cerebral palsy. Dev Med Child Neurol 1980; 22: 497.
Tardieu G, Tardieu C, Hariga J, Gagnard L. Treatment of spasticity by injection of dilute alcohol at the motor point or by epidural route. Clinical extension of an experiment on the decerebrate cat. Dev Med Child Neurol 1968; 10: 555.
Silver RL, Rang M, Chan J, de la Garza J. Adductor release of nonambulant children with cerebral palsy. J Pediatr Orthop 1985; 5: 672.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer Science+Business Media New York
About this chapter
Cite this chapter
Koman, L.A., Mooney, J.F., Smith, B.P. (1993). The Use of Botulinum Toxin in the Management of Cerebral Palsy in Pediatric Patients. In: DasGupta, B.R. (eds) Botulinum and Tetanus Neurotoxins. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-9542-4_64
Download citation
DOI: https://doi.org/10.1007/978-1-4757-9542-4_64
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-9544-8
Online ISBN: 978-1-4757-9542-4
eBook Packages: Springer Book Archive